Kantonsspital St.Gallen
login

IFX-1-P2.5

Riana Peischl, Thomas Neumann & Andrea Rubbert Roth

abstract a randomized, double-blind, double-dummy, active-controlled, multicenter, 2-part Phase 2 study on replacement of steroids by IFX-1 in active granulomatosis with polyangiitis (GPA) and microscopic polyangitis (MPA)
   
type of project clinical studies
status completed
start of project 2020
end of project 2021
study design This is a prospective, randomized, double-blind, double-dummy, active-controlled, multicenter, 2-part Phase 2 study. a total of 3 treatment groups will be investigated:
Group A: IFX-1 + reduced-dose GC
Group B: Placebo-IFX-1 + stadard-dose GC
Group C: IFX-1 + no GC
responsible person Dr.Thomas Neumann